StudyFinder
ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)
Recruiting
This is a global, multicenter, prospective, observational, longitudinal registry conducted to characterize the natural history and real-world clinical management of patients diagnosed with AHP. This protocol will not recommend the use of any specific treatments, visits, or procedures. No medication is provided as part of registry participation.
Male or Female
12 years and over
Inclusion Criteria:
* Documented diagnosis of AHP, per physician's determination
Exclusion Criteria:
* Currently enrolled in a clinical trial for any investigational agentDigestive & Liver Health, Rare Diseases
Clinics and Surgery Center (CSC)
Diondra Howard - howar709@umn.edu
Gregory Vercellotti
SITE00001194
See this study on ClinicalTrials.gov